We are live on
!
Find out more
VAM
Visium Asset Management Portfolio holdings
AUM
$1.43B
1-Year Est. Return
3.58%
This Fund
S&P 500
This Quarter
Est. Return
+13.68%
1 Year Est. Return
-3.58%
3 Year Est. Return
+100.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$6.18B
AUM Growth
+$1.08B
(+21%)
Cap. Flow
+$404M
Cap. Flow
% of AUM
6.55%
Top 10 Holdings %
Top 10 Hldgs %
31.51%
Holding
1,163
New
297
Increased
261
Reduced
271
Closed
313
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ENDP
Endo International plc
ENDP
|
+$197M |
| 2 |
AGN
Allergan plc
AGN
|
+$135M |
| 3 |
Bausch Health
BHC
|
+$129M |
| 4 |
CVS Health
CVS
|
+$107M |
| 5 |
McKesson
MCK
|
+$94.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$286M |
| 2 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
+$225M |
| 3 |
Gilead Sciences
GILD
|
+$86.1M |
| 4 |
Perrigo
PRGO
|
+$79.4M |
| 5 |
Cardinal Health
CAH
|
+$74.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 53.16% |
| 2 | Consumer Discretionary | 5.06% |
| 3 | Energy | 4.01% |
| 4 | Utilities | 3.23% |
| 5 | Financials | 3.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Genworth Financial
GNW
$3.76B
| $7.87M | 0.13% |
+443,645
| New | +$7.12M |
|
152
IDEX
IEX
$17B
| $7.85M | 0.13% |
+107,736
| New | +$7.84M |
|
|
ZLTQ
153
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
| $7.84M | 0.13% |
400,000
-50,000
| -11% | -$975K |
|
154
Whirlpool
WHR
$2.43B
| $7.82M | 0.13% |
52,323
+44,613
| +579% | +$6.46M |
|
155
Televisa
TV
$1.48B
| $7.81M | 0.13% |
234,467
+121,169
| +107% | +$3.65M |
|
|
COV
156
DELISTED
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
| $7.68M | 0.12% |
+104,200
| New | +$7.27M |
|
157
Mattel
MAT
$4.38B
| $7.64M | 0.12% |
+190,427
| New | +$7.56M |
|
|
ACCL
158
CALL
DELISTED
Accelrys Inc
ACCL
| $7.58M | 0.12% |
+608,200
| New | +$7.12M |
|
|
BEAM
159
DELISTED
BEAM INC COM STK (DE)
BEAM
| $7.56M | 0.12% |
90,744
-221,727
| -71% | -$18M |
|
|
KOG
160
DELISTED
KODIAK OIL & GAS CORP
KOG
| $7.38M | 0.12% |
+608,299
| New | +$6.88M |
|
161
Reliance Steel & Aluminium
RS
$20.7B
| $7.37M | 0.12% |
104,309
+32,467
| +45% | +$2.32M |
|
162
Truist Financial
TFC
$63.3B
| $7.36M | 0.12% |
183,095
+153,458
| +518% | +$5.87M |
|
|
SGI
163
Somnigroup International
SGI
$13.7B
| $7.34M | 0.12% |
579,104
-119,708
| -17% | -$1.49M |
|
164
Ralph Lauren
RL
$22.6B
| $7.33M | 0.12% |
45,530
+7,831
| +21% | +$1.26M |
|
165
Henry Schein
HSIC
$9.77B
| $7.26M | 0.12% |
155,129
-40,502
| -21% | -$1.85M |
|
|
SVA
166
DELISTED
Sinovac Biotech, Ltd
SVA
| $7.2M | 0.12% |
1,000,000
| – | – |
|
|
ASPX
167
DELISTED
AUSPEX PHARMACEUTICALS INC COM STK (DE)
ASPX
| $7.19M | 0.12% |
+233,625
| New | +$6.28M |
|
|
ELGX
168
DELISTED
Endologix Inc
ELGX
| $7.1M | 0.11% |
55,132
-410
| -0.7% | -$63.8K |
|
|
FL
169
DELISTED
Foot Locker
FL
| $7.06M | 0.11% |
+150,262
| New | +$6.24M |
|
170
Achieve Life Sciences
ACHV
$659M
| $7.04M | 0.11% |
272
-1
| -0.4% | -$24.6K |
|
171
Vodafone
VOD
$36.3B
| $7.01M | 0.11% |
190,440
+43,308
| +29% | +$1.67M |
|
172
PUT
Best Buy
BBY
$18.2B
| $7M | 0.11% |
+265,000
| New | +$7.26M |
|
173
News Corp Class A
NWSA
$14.9B
| $6.95M | 0.11% |
403,410
+229,101
| +131% | +$3.96M |
|
|
RXDX
174
DELISTED
Ignyta, Inc.
RXDX
| $6.92M | 0.11% |
+833,000
| New | +$7.8M |
|
|
BRCM
175
DELISTED
BROADCOM CORP CL-A
BRCM
| $6.79M | 0.11% |
215,779
-13,960
| -6% | -$420K |
|
Similar funds
FBNAT
CPS
LH
CPM
VFS
ZA
FVFIGP
WA
Visium Asset Management's Q1 2014 Portfolio in Review
As of Q1 2014, Visium Asset Management held 1,163 positions worth $6.18B, up 21% from $5.09B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Visium Asset Management deployed $404M of net new capital in Q1 2014, opening 297 new positions and adding to 261 existing holdings. Its largest new stake was Regeneron Pharmaceuticals: 286,563 shares worth $86M.
By sector, the portfolio is most concentrated in Healthcare at 53% of assets, down from 54% a quarter earlier, followed by Consumer Discretionary and Energy.
On the sell side, the largest reduction was Allergan Inc, an estimated $286M trimmed.
- Visium Asset Management's largest Q1 2014 buy was Regeneron Pharmaceuticals: 286,563 shares worth $86M.
- Visium Asset Management added most to Endo International plc in Q1 2014, an estimated $197M increase.
- Visium Asset Management's biggest Q1 2014 reduction was Allergan Inc, cutting an estimated $286M.
- Visium Asset Management fully exited Momenta Pharmaceuticals, Inc. in Q1 2014, selling an estimated $64M.
- Visium Asset Management's ten largest holdings make up 32% of its $6.18B portfolio in Q1 2014.
- Visium Asset Management opened 297 new positions and closed 313 in Q1 2014.
- Visium Asset Management's portfolio value rose 21% quarter-over-quarter to $6.18B.
Based on Visium Asset Management's 13F filing for Q1 2014, filed 15 May 2014.